Document:

LICENSE AND SUPPLY AGREEMENT

This License Agreement is entered into as of this 18th of May, 2007 (the
effective date), by and among DIET COFFEE, Inc. (the "Licensee") having offices
at 16 East 40th Street, New York, N.Y. 10016 and Jason Ryu (Patent Holder,
Licensor) residing at 21 Veterans Way Edgewater, New Jersey.

Whereas: Licensor is the inventor of and sole owner of the device, described
"The Ionic Bulb;" and

Whereas: Licensor is the sole owner of United States Patent US2006/0078460,
International Patent PCT/KR2005/002997, and Korea Patent KR10-2004-74598 which
describes said device; and

Whereas: Licensor, and Licensee, which to enter into an agreement whereby said
device, and products derived from and based upon said device may be successfully
marketed,

In consideration of the mutual promises contained below, the parties agree as
follows:

SECTION 1 - LICENSE RIGHTS

1) Licensor owns all rights to the "The Ionic Bulb" (the "Licensed Product"),
including the "Patent Rights" for the Licensed Product. "Patent Rights" shall
mean: All U.S. and foreign patents and patent applications for the Licensed
Product, and any later-filed United States and/or foreign patent applications
for an Ionic Bulb based on U.S. Patent No. 2006/0078460, or corresponding
thereto, including any improvements, continuations, continuations-in-part,
divisional, reissues, reexaminations, or extensions thereof.

2) The Grant - The Licensor hereby grants to the Licensee and the Licensee
accepts, subject to the terms and conditions of this Agreement, an exclusive,
commercial license, subject to Licensor's reserve list, within the "Territory,"
as defined below, in all fields of use under the Patent Rights, and a license to
make, have made, use, lease and/or sell the Licensed Product (the "Grant").
Licensee agrees to use its reasonable, best efforts to promote the sale of the
"Products" in the "Territory", subject to the terms and conditions set forth
below and further to use its reasonable, best efforts to fill all orders secured
by it for the "Product."

3) Licensee agrees to sell the Licensed Product to Licensor at preferred prices
of the sum of costs of production, royalties, insurance and shipping plus
10%(ten percent) for sales to Licensors reserve list. Licensor's "reserve list"
shall mean the non-exclusive right to sell the Licensed Product within the
Territory to (i) Asian societies, (ii) governments, (iii) industrial users, and
(iv) hotels and schools.

<PAGE>

3) The "Territory" consists of the entire world, except for Japan; Korea, and
the Peoples Republic of China.

4) Licensor warrants that it holds all rights to the Licensed Product, and
products derived from and based upon said device throughout the "Territory".

5) Any claims arising in jurisdictions covered by the Product PCT made by third
parties regarding the ownership of the rights that are claimed to be held by
Licensor shall be the responsibility of Licensor and Licensor agrees to
indemnify, and hold harmless, the Licensee, from any claim asserted based upon
Contract, and/or Patent or Trademark infringement.

6) The term of this License Agreement shall be for two years, during which
period Licensee shall purchase at least five million units of the Licensed
Product. The failure of Licensee to purchase five million units during the
initial term shall give Licensor the right to cancel this agreement after the
initial term, but shall not give rise to any obligation of Licensee to pay any
shortfall of Royalty to Licensor. If Licensee shall purchase at least five
million units during the initial term, this License shall automatically renew
for another two year term, and shall continue to renew for successive terms of
two years for the life of any rights arising under the Patent Rights, provided
Licensee shall purchase at least five million units in each prior term.

7) Within ninety (90) days from the date of this Agreement, Licensee shall place
an order not less than 100,000 units and at least 600,000 units each quarter
thereafter.

SECTION 2 - Royalties

1) Licensor shall receive, from Licensee, $0.20 per unit for first 1.5 million
units and $0.15 per unit thereafter or [CONFIDENTIAL TREATMENT REQUESTED] of
manufacturing cost, whichever is less.

2) Licensee anticipates minimum royalty payments of $825,000 in the initial term
of this Agreement.

3) Licensee shall pay royalty to Licensor upon receipt of goods from the
manufacturer. All such goods shall be ordered by Licensee.

SECTION 3 - DUTIES OF LICENSOR

1) At the Licensee's request, Licensor will supply Licensee with all available
studies; testimonials; clinical studies, certificates; approvals and or results,
pertaining to the Licensed Product, promotional and advertising, including the
master tape of all commercials relating to the Licensed Product and control over
all web sites and domain names pertaining to the Licensed Product, including
www.ionicbulb.com and ioniclight.com.

<PAGE>

2) Licensor shall maintain product liability insurance in the amount of one
million dollars per occurrence, and shall name Licensee as an added named
insured under said policy. Licensor shall provide a copy of said policy to
Licensee.

3) The marketing rights granted herein are exclusive and Licensor agrees not to
manufacture or market, nor allow a third-party to manufacture or market, the
Licensed Product or product similar in composition or function, for itself or
for third parties, in competition with Licensee's marketing efforts in the
Territory during the "Term" of this agreement.

4) Licensor shall not present the product to anyone without written consent of
Licensee.

SECTION 4 - DUTIES OF LICENSEE

1) Licensee will provide the promotional, advertising and fulfillment materials
necessary to satisfy "Territorial" statutory and regulatory requirements.

2) Licensee agrees to use its reasonable best efforts to provide information on
any competitive products that may come to the attention of Licensee.

3) Licensee may assign its rights hereunder upon written approval from Licensor,
such consent not to be unreasonably withheld.

SECTION 5 - Confidentiality

Each of the Parties agrees not to disclose (i) confidential information
regarding the Product's construction, technical information, designs, drawings,
concepts, ideas, sketches, wordings, media or marketing strategies, or
composition, (ii) confidential information regarding the spot production, and
(iii) confidential information regarding the other party, or such other party's
companies, products, or operations, or any other company information which may
be deemed a trade secret, or is sensitive in nature and not otherwise known to
the public, including the contents of this agreement ("Information"), without
the prior written consent of such other party. Notwithstanding the foregoing,
disclosure may be made to persons on a need to know basis to effectuate the
purposes herein (such as third-party auditors and distributors, buyers and sales
representatives )or by court order, or as otherwise provided herein so long as
the recipient of such Information agrees to treat all such Information in strict
confidence.

SECTION 6 - Manufacture and Supply

1) Product - A basic unit of the Product consists of one negative ion generator
("NIG") and a compact fluorescent lamp ("CFL").

<PAGE>

2) Manufacture and Supply of the Licensed Product - Upon execution of this
Agreement, Licensor shall (i) provide Licensee with all manufacturing
information and know-how related to the production of the Licensed Product; (ii)
contact information for Licensor's manufacturers of the NIG and the CFL for the
Licensed Product.

3) Authority to Buy Direct - Licensor hereby authorizes Licensee to deal
directly with Licensor's manufacturer of the Licensed Product and agrees to
provide Licensee with introductions to the manufacturer of the Licensed Product
("Manufacturer").

4) Licensor agrees to supply to Licensee, within the Initial Term for this
Agreement, Licensee's total requirements for NIG's in accordance with the terms
and conditions of this Agreement, at a price not to exceed [CONFIDENTIAL
TREATMENT REQUESTED].Any price adjustments after the initial term shall be based
on prices acceptable to the licensee.

5) Manufacturing Option - Should the Parties mutually determine at any time
during the term of this Agreement that it is not feasible for Licensor to supply
NIG's, or should Licensor fail to timely fill Licensee's orders for NIG's or
meet appropriate quality standards in accordance with this Agreement, then
Licensee shall have the option to manufacture or arrange for a third-party to
manufacture NIG's for the duration of the term of this agreement. Upon
Licensee's exercise of this option, Licensor shall supply NIG design, and
manufacturing specifications and Licensee shall assume all manufacturing rights
and responsibilities which were formerly Licensor's rights and responsibilities
pursuant to this Agreement.

6) Notwithstanding any other provisions to this agreement, Licensee's
obligations hereunder shall commence only upon receipt by Licensee from
Manufacturer of reasonable assurances that Manufacturer shall supply Licensees
requirements for the Licensed Product during the Initial Term of this Agreement
at a price not to exceed [CONFIDENTIAL TREATMENT REQUESTED] per unit FOB China.
Any failure of Licensee to meet its duties under this Agreement, which is wholly
or partly attributable to the Manufacturer to supply the Licensed Product to
Licensee or Licensor failure to supply NIG's to Licensee, each in a timely
manner, in accordance with appropriate quality standards and according to
Licensee's requirements, shall not constitute a breach of this Agreement on the
part of Licensee and shall not effect the Grant to Licensee provided in this
Agreement.

SECTION 7 -- RELATIONS OF THE PARTIES

1) Additional Products; First Right of Refusal - Licensor is in the process of
developing Ionic Products, each of which Licensee shall have the first right of
refusal to market in varying product configurations along with Product pursuant
to the terms herein.

2) Neither party nor any of its employees, representatives or agents will be or
act or purport to act as employee, representative or agent of the other party
for any reason whatsoever.

<PAGE>

SECTION 8 - TERMINATION OF AGREEMENT

1) Any party seeking termination of this Agreement for default in performance
herein described must give not less than thirty (30) days prior written notice
by certified mail or facsimile, to the other party in default, specifying the
nature of the default.

2) In the event the defaulting party cures the default within thirty (30) days
after the required notice described in paragraph 1 (above), then this Agreement
will not terminate.

SECTION 9 - GOVERNING LAW

1) This Agreement shall be interpreted under the Laws of New York State, U.S.A.

SECTION 10 - CONTRACT ACKNOWLEDGMENT

This Agreement constitutes the entire Agreement between the parties hereto. No
change, modification or amendment of this Agreement is binding upon Licensor and
Licensee unless made in writing and signed by both parties.

LICENSOR                                LICENSEE: DIET COFFEE, INC

     /s/ Jason Ryu                          /s/ David Stocknoff
-------------------------------         ----------------------------------------
Individually   Jason Ryu                President   David Stocknoff

                                            /s/ David Attarian
                                        ----------------------------------------
                                        Secretary   David AttarianUnassociated Document

    SECURITIES
      PURCHASE AGREEMENT

     

    

     

    SECURITIES
      PURCHASE AGREEMENT (“Agreement”),
      dated
      as of August 13, 2007, by and among Innofone.com., Inc., a Nevada corporation,
      with headquarters at 1431 Ocean Ave. Suite 1100, Santa Monica, California,
      90401
      (the “Company”),
      and
      James and Lisa Goodell, residing at 1178 17th
      Avenue,
      McPherson, Kansas 67460 (the “Purchaser”).

     

    WHEREAS:
      

     

    A. The
      Company and the Purchaser are executing and delivering this Agreement in
      reliance upon the exemption from securities registration afforded by the rules
      and regulations as promulgated by the United States Securities and Exchange
      Commission (the “SEC”) under the Securities Act of 1933, as amended (the “1933
      Act”);

     

    B. The
      Purchaser desires to purchase and the Company desires to issue and sell, upon
      the terms and conditions set forth in this Agreement (i) Seven Hundred
      Sixty Nine Thousand Two Hundred Thirty (769,230) shares of common stock, par
      value $.001 per share (the “Common
      Stock”),
      of
      the Company (the “Shares”)
      and
      (ii) a warrant, in the form attached hereto as Exhibit
      “A”,
      to
      purchase Seven Hundred Sixty Nine Thousand Two Hundred Thirty (769,230) shares
      of Common Stock (the “Warrant”);
      and

     

    C. The
      Purchaser wishes to purchase, upon the terms and conditions stated in this
      Agreement, the Shares and the Warrant.

     

    NOW
      THEREFORE,
      the
      Company and the Purchaser hereby agree as follows:

     

    1. PURCHASE
      AND SALE OF SHARES AND WARRANT.

     

    a. Purchase
      of Shares and Warrant.
      On the
      Closing Date (as defined below), the Company shall issue and sell to the
      Purchaser and the Purchaser agrees to purchase from the Company the Shares
      and
      the Warrant.

     

    b. Form
      of Payment.
      On the
      Closing Date (as defined below), (i) the Purchaser shall pay Fifty Thousand
      Dollars ($50,000), the purchase price for the Shares and the Warrant to be
      issued and sold to it at the Closing (as defined below) (the “Purchase
      Price”),
      by
      wire transfer of immediately available funds to the Company, in accordance
      with
      the Company’s written wiring instructions, against delivery of the Shares and
      the Warrant, and (ii) the Company shall deliver such Shares and the Warrant
      duly executed on behalf of the Company, to such Purchaser, against delivery
      of
      such Purchase Price. 

     

    c. Closing
      Date.
      Subject
      to the satisfaction (or written waiver) of the conditions thereto set forth
      in
      Section 7 and Section 8 below, the date and time of the issuance and sale of
      the
      Shares and the Warrant pursuant to this Agreement (the “Closing
      Date”)
      shall
      be the date in which the Agreement is mutually executed by the parties, or
      such
      other mutually agreed upon time. The closing of the transactions contemplated
      by
      this Agreement (the “Closing”)
      shall
      occur on the Closing Date at such location as may be agreed to by the
      parties.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

     

    2. BUYER’S
      REPRESENTATIONS AND WARRANTIES.
      The
      Purchaser represents and warrants to the Company that:

     

    a. Investment
      Purpose.
      As of
      the date hereof, the Purchaser is purchasing the Shares and the Warrant and
      the
      shares of Common Stock issuable upon exercise thereof (the “Warrant
      Shares”
and,
      collectively with Shares, the “Securities”)
      for
      its own account and not with a present view towards the public sale or
      distribution thereof, except pursuant to sales registered or exempted from
      registration under the 1933 Act; provided,
      however,
      that by
      making the representations herein, the Purchaser does not agree to hold any
      of
      the Securities for any minimum or other specific term and reserves the right
      to
      dispose of the Securities at any time in accordance with or pursuant to a
      registration statement or an exemption under the 1933 Act.

     

    b. Accredited
      Investor Status.
      The
      Purchaser is an “accredited investor” as that term is defined in Rule 501(a) of
      Regulation D (an “Accredited
      Investor”).

     

    c. Reliance
      on Exemptions.
      The
      Purchaser understands that the Securities are being offered and sold to it
      in
      reliance upon specific exemptions from the registration requirements of United
      States federal and state securities laws and that the Company is relying upon
      the truth and accuracy of, and the Purchaser’s compliance with, the
      representations, warranties, agreements, acknowledgments and understandings
      of
      the Purchaser set forth herein in order to determine the availability of such
      exemptions and the eligibility of the Purchaser to acquire the
      Securities.

     

    d. Information.
      The
      Purchaser and its advisors, if any, have been furnished with all materials
      relating to the business, finances and operations of the Company and materials
      relating to the offer and sale of the Securities which have been requested
      by
      the Purchaser or its advisors. The Purchaser and its advisors, if any, have
      been
      afforded the opportunity to ask questions of the Company. The Purchaser
      understands that its investment in the Securities involves a significant degree
      of risk.

     

    e. Certain
      Changes.
      The
      Purchaser understands that since March 31, 2007, there has been a material
      adverse change in the assets, liabilities, business, properties, operations,
      financial condition or results of operations of the Company. The Purchaser
      has
      reviewed and understands all of the Company’s reports, schedules, forms,
      statements and other documents filed with the Securities and Exchange
      Commission. The Purchaser understands that (i) the Company expects to continue
      to require substantial capital following completion of this current offering
      in
      order to fund its operations, (ii) such additional capital may not be available
      when needed on terms the Company considers reasonable, or at all, and (iii)
      any
      inability to raise sufficient additional capital could compel the Company to
      discontinue some or all of its operations.

     

    f. Governmental
      Review.
      The
      Purchaser understands that no United States federal or state agency or any
      other
      government or governmental agency has passed upon or made any recommendation
      or
      endorsement of the Securities.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    

     

    g. Transfer
      or Re-sale.
      The
      Purchaser understands that (i)  the sale or re-sale of the Securities has
      not been and is not being registered under the 1933 Act or any applicable state
      securities laws, and the Securities may not be transferred unless (a) the
      Securities are sold pursuant to an effective registration statement under the
      1933 Act, (b) the Purchaser shall have delivered to the Company an opinion
      of counsel that shall be in form, substance and scope customary for opinions
      of
      counsel in comparable transactions to the effect that the Securities to be
      sold
      or transferred may be sold or transferred pursuant to an exemption from such
      registration, which opinion shall be accepted by the Company, (c) the
      Securities are sold or transferred to an “affiliate” (as defined in Rule 144
      promulgated under the 1933 Act (or a successor rule) (“Rule
      144”))
      of
      the Purchaser who agrees to sell or otherwise transfer the Securities only
      in
      accordance with this Section 2(f) and who is an Accredited Investor,
      (d) the Securities are sold pursuant to Rule 144, or (e) the
      Securities are sold pursuant to Regulation D under the 1933 Act (or a successor
      rule) (“Regulation
      D”);
      (ii)
      any sale of such Securities made in reliance on Rule 144 may be made only in
      accordance with the terms of said Rule and further, if said Rule is not
      applicable, any re-sale of such Securities under circumstances in which the
      seller (or the person through whom the sale is made) may be deemed to be an
      underwriter (as that term is defined in the 1933 Act) may require compliance
      with some other exemption under the 1933 Act or the rules and regulations of
      the
      SEC thereunder; and (iii) neither the Company nor any other person is under
      any
      obligation to register such Securities under the 1933 Act or any state
      securities laws or to comply with the terms and conditions of any exemption
      thereunder. Notwithstanding the foregoing or anything else contained herein
      to
      the contrary, the Securities may be pledged as collateral in connection with
      a
bona fide
      margin
      account or other lending arrangement. 

     

    h. Legends.
      The
      Purchaser understands that the Shares and the Warrant and, until such time
      as
      the Shares and Warrant Shares have been registered under the 1933 Act or
      otherwise may be sold pursuant to Rule 144 or Regulation D without any
      restriction as to the number of securities as of a particular date that can
      then
      be immediately sold, the Shares and Warrant Shares may bear a restrictive legend
      in substantially the following form (and a stop-transfer order may be placed
      against transfer of the certificates for such Securities):

     

    “The
      securities represented by this certificate have not been registered under the
      Securities Act of 1933, as amended. The securities may not be sold, transferred
      or assigned in the absence of an effective registration statement for the
      securities under said Act, or an opinion of counsel, in form, substance and
      scope customary for opinions of counsel in comparable transactions, that
      registration is not required under said Act or unless sold pursuant to Rule
      144
      or Regulation D under said Act.”

     

    The
      legend set forth above shall be removed and the Company shall issue a
      certificate without such legend to the holder of any Security upon which it
      is
      stamped, if, unless otherwise required by applicable state securities laws,
      (a)
      such Security is registered for sale under an effective registration statement
      filed under the 1933 Act or otherwise may be sold pursuant to Rule 144 or
      Regulation D without any restriction as to the number of securities as of a
      particular date that can then be immediately sold, or (b) such holder provides
      the Company with an opinion of counsel, in form, substance and scope customary
      for opinions of counsel in comparable transactions, to the effect that a public
      sale or transfer of such Security may be made without registration under the
      1933 Act, which opinion shall be accepted by the Company so that the sale or
      transfer is effected or (c) such holder provides the Company with reasonable
      assurances that such Security can be sold pursuant to Rule 144 or Regulation
      D.
      The Purchaser agrees to sell all Securities, including those represented by a
      certificate(s) from which the legend has been removed, in compliance with
      applicable prospectus delivery requirements, if any.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    

     

    i. Authorization;
      Enforcement.
      This
      Agreement has been duly and validly authorized. This Agreement has been duly
      executed and delivered on behalf of the Purchaser, and this Agreement
      constitutes a valid and binding agreement of the Purchaser enforceable in
      accordance with its terms.

     

    j. Residency.
      The
      Purchaser is a resident of the jurisdiction set forth immediately below such
      Purchaser’s name on the signature pages hereto. 

     

    3. REPRESENTATIONS
      AND WARRANTIES OF THE COMPANY.
      The
      Company represents and warrants to the Purchaser that: 

     

    a. Organization
      and Qualification.
      The
      Company is a corporation duly organized, validly existing and in good standing
      under the laws of the jurisdiction in which it is incorporated, with full power
      and authority (corporate and other) to own, lease, use and operate its
      properties and to carry on its business as and where now owned, leased, used,
      operated and conducted. The Company is duly qualified as a foreign corporation
      to do business and is in good standing in every jurisdiction in which its
      ownership or use of property or the nature of the business conducted by it
      makes
      such qualification necessary except where the failure to be so qualified or
      in
      good standing would not have a Material Adverse Effect. “Material
      Adverse Effect”
means
      any of (i) a material and adverse effect on the legality, validity or
      enforceability of any document executed in connection with this financing,
      or
      (ii) a material and adverse effect on the results of operations, assets,
      business or financial condition of the Company.

     

    b. Authorization;
      Enforcement.
      (i) The
      Company has all requisite corporate power and authority to enter into and
      perform this Agreement and the Warrant and to consummate the transactions
      contemplated hereby and thereby and to issue the Securities, in accordance
      with
      the terms hereof and thereof, (ii) the execution and delivery of this Agreement
      and the Warrant by the Company and the consummation by it of the transactions
      contemplated hereby and thereby (including without limitation, the issuance
      of
      the Shares and the Warrant and the issuance and reservation for issuance of
      the
      Warrant Shares issuable upon conversion or exercise thereof) have been duly
      authorized by the Company’s Board of Directors and no further consent or
      authorization of the Company, its Board of Directors, or its shareholders is
      required, (iii) this Agreement has been duly executed and delivered by the
      Company by its authorized representative, and such authorized representative
      is
      the true and official representative with authority to sign this Agreement
      and
      the other documents executed in connection herewith and bind the Company
      accordingly, and (iv) this Agreement constitutes, and upon execution and
      delivery by the Company of the Warrant, each of such instruments will
      constitute, a legal, valid and binding obligation of the Company enforceable
      against the Company in accordance with its terms.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    

     

    c. Capitalization.
      As of
      the date hereof, the authorized capital stock of the Company consists of (i)
      975,000,000 shares of Common Stock, par value $.001 per share, of which
      96,729,557 shares are issued and outstanding and (ii) [4,815,000] shares of
      preferred stock, of which none are issued and outstanding. All of such
      outstanding shares of capital stock are, or upon issuance will be, duly
      authorized, validly issued, fully paid and nonassessable. No shares of capital
      stock of the Company are subject to preemptive rights or any other similar
      rights of the shareholders of the Company or any liens or encumbrances imposed
      through the actions or failure to act of the Company. Except as disclosed in
      Schedule
      3(c),
      as of
      the effective date of this Agreement, (i) there are no outstanding options,
      warrants, scrip, rights to subscribe for, puts, calls, rights of first refusal,
      agreements, understandings, claims or other commitments or rights of any
      character whatsoever relating to, or securities or rights convertible into
      or
      exchangeable for any shares of capital stock of the Company, or arrangements
      by
      which the Company is or may become bound to issue additional shares of capital
      stock of the Company, (ii) there are no agreements or arrangements under which
      the Company is obligated to register the sale of any of its or their securities
      under the 1933 Act and (iii) there are no anti-dilution or price adjustment
      provisions contained in any security issued by the Company (or in any agreement
      providing rights to security holders) that will be triggered by the issuance
      of
      the Shares, the Warrant or Warrant Shares. The Company has furnished to the
      Purchaser true and correct copies of the Company’s Certificate of Incorporation
      as in effect on the date hereof (“Certificate
      of Incorporation”),
      the
      Company’s By-laws, as in effect on the date hereof (the “By-laws”),
      and
      the terms of all securities convertible into or exercisable for Common Stock
      of
      the Company and the material rights of the holders thereof in respect thereto.
      

     

    d. Issuance
      of Shares.
      The
      Shares and Warrant Shares are duly authorized and reserved for issuance and,
      upon exercise of the Warrant in accordance with their respective terms, will
      be
      validly issued, fully paid and non-assessable, and free from all taxes, liens,
      claims and encumbrances with respect to the issue thereof and shall not be
      subject to preemptive rights or other similar rights of shareholders of the
      Company and will not impose personal liability upon the holder
      thereof.

     

    e. No
      Conflicts.
      The
      execution, delivery and performance of this Agreement and the Warrant by the
      Company and the consummation by the Company of the transactions contemplated
      hereby and thereby (including, without limitation, the issuance and reservation
      for issuance of the Shares and Warrant Shares) will not (i) conflict with or
      result in a violation of any provision of the Certificate of Incorporation
      or
      By-laws or (ii) result in a violation of any law, rule, regulation, order,
      judgment or decree (including federal and state securities laws and regulations
      and regulations of any self-regulatory organizations to which the Company or
      its
      securities are subject) applicable to the Company or by which any property
      or
      asset of the Company is bound or affected (except for such conflicts, defaults,
      terminations, amendments, accelerations, cancellations and violations as would
      not, individually or in the aggregate, have a Material Adverse Effect). The
      Company is not in violation of its Certificate of Incorporation, By-laws or
      other organizational documents and the Company is not in default (and no event
      has occurred which with notice or lapse of time or both could put the Company)
      under, and the Company has not taken any action or failed to take any action
      that would give to others any rights of termination, amendment, acceleration
      or
      cancellation of, any agreement, indenture or instrument to which the Company
      is
      a party or by which any property or assets of the Company is bound or affected,
      except for possible defaults as would not, individually or in the aggregate,
      have a Material Adverse Effect. The businesses of the Company are not being
      conducted, and shall not be conducted so long as a Purchaser owns any of the
      Securities, in violation of any law, ordinance or regulation of any governmental
      entity. Except as specifically contemplated by this Agreement and as required
      under the 1933 Act and any applicable state securities laws, the Company is
      not
      required to obtain any consent, authorization or order of, or make any filing
      or
      registration with, any court, governmental agency, regulatory agency, self
      regulatory organization or stock market or any third party in order for it
      to
      execute, deliver or perform any of its obligations under this Agreement or
      the
      Warrant in accordance with the terms hereof or thereof or to issue and sell
      the
      Shares and Warrant in accordance with the terms hereof and to issue the Shares
      and the Warrant Shares upon exercise of the Warrant. 

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    

     

    f. No
      Brokers.
      Except
      as set forth in Schedule
      3(j),
      the
      Company has taken no action which would give rise to any claim by any person
      for
      brokerage commissions, transaction fees or similar payments relating to this
      Agreement or the transactions contemplated hereby. 

     

    g. Permits;
      Compliance.
      The
      Company is in possession of all franchises, grants, authorizations, licenses,
      permits, easements, variances, exemptions, consents, certificates, approvals
      and
      orders necessary to own, lease and operate its properties and to carry on its
      business as it is now being conducted (collectively, the “Company
      Permits”),
      and
      there is no action pending or, to the knowledge of the Company, threatened
      regarding suspension or cancellation of any of the Company Permits. The Company
      is not in conflict with, or in default or violation of, any of the Company
      Permits, except for any such conflicts, defaults or violations which,
      individually or in the aggregate, would not reasonably be expected to have
      a
      Material Adverse Effect. 

     

    4. COVENANTS.

     

    a. Form
      D; Blue Sky Laws.
      The
      Company agrees to file a Form D with respect to the Securities as required
      under
      Regulation D and to provide a copy thereof to each Purchaser promptly after
      such
      filing. The Company shall, on or before the Closing Date, take such action
      as
      the Company shall reasonably determine is necessary to qualify the Securities
      for sale to the Purchaser at the applicable closing pursuant to this Agreement
      under applicable securities or “blue sky” laws of the states of the United
      States (or to obtain an exemption from such qualification), and shall provide
      evidence of any such action so taken to each Purchaser on or prior to the
      Closing Date.

     

    b. Authorization
      and Reservation of Shares.
      The
      Company shall at all times have authorized, and reserved for the purpose of
      issuance, a sufficient number of shares of Common Stock to provide for the
      full
      exercise of the outstanding Warrant and issuance of the Warrant Shares in
      connection therewith (based on the Exercise Price of the Warrant in effect
      from
      time to time). The Company shall not reduce the number of shares of Common
      Stock
      reserved for issuance upon exercise of the Warrant without the consent of the
      Purchaser. 

     

    5. OPTIONAL
      REDEMPTION.
      Prior
      to the third anniversary of the Closing Date, the Company shall have the right,
      exercisable on not less than ten (10) business dates prior written notice to
      the
      Purchaser, to redeem all or a portion of the outstanding Shares issued pursuant
      to this Agreement in accordance with this Section 5. Any notice of redemption
      hereunder shall be delivered to the Purchaser at its registered addresses
      appearing on the books and records of the Company and shall state (1) that
      the
      Company is exercising its right to redeem all or a portion of the Shares issued
      to the Purchaser, (2) the date of redemption and (3) the amount of the
      redemption. On the date fixed for redemption (the “Optional
      Redemption Date”),
      the
      Company shall make payment of the Optional Redemption Amount (as defined below)
      to or upon the order of the Purchaser as specified by the Purchaser in writing
      to the Company at least one (1) business day prior to the Optional Redemption
      Date. If the Company exercises its right to redeem the Shares, the Company
      shall
      make payment to the Purchaser of an amount in cash (the “Optional
      Redemption Amount”)
      equal
      to 200% multiplied by the Purchase Price. If the Company exercises its right
      to
      redeem a portion of the Shares, the Company shall make payment to the Purchaser
      of an amount in cash equal to $0.26 per share (as adjusted for any stock splits,
      dividends, recapitalizations and the like) of Common Stock to be so
      redeemed.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    

     

    6. Anti-Dilution
      Protection.
      In the
      event that the Company consummates a sale of equity securities (a “Financing”),
      and
      the price per share of such equity securities sold in such Financing is less
      than $0.065 per share (as adjusted for stock splits, dividends,
      recapitalizations and the like), the Purchaser who purchased Shares hereunder
      shall receive such additional number of Shares so that the Purchase Price shall
      equal the price per share in the Financing. 

     

    a. Exceptions
      to Anti-Dilution Protection.
      No
      Shares will be granted to the Purchaser pursuant to this Section 6 (i) upon
      the
      exercise of any warrants, options or convertible securities granted, issued
      and
      outstanding on the Closing Date; (ii) upon the grant or exercise of any stock
      or
      options which may hereafter be granted or exercised under any employee benefit
      plan, stock option plan or restricted stock plan of the Company now existing
      or
      to be implemented in the future, so long as the issuance of such stock or
      options is approved by a majority of the independent members of the Board of
      Directors of the Company or a majority of the members of a committee of
      independent directors established for such purpose; (iii) upon the issuance
      of
      any securities in connection with an acquisition by the Company, so long as
      such
      acquisition is approved by a majority of the independent members of the Board
      of
      Directors of the Company or a majority of the members of a committee of
      independent directors established for such purpose; (iv) upon the issuance
      of
      any securities pursuant to a commitment by the Company that has been previously
      disclosed to the holder prior to the date hereof; or (v) upon the exercise
      of
      the Warrant.

     

    7. CONDITIONS
      TO THE COMPANY’S OBLIGATION TO SELL.
      The
      obligation of the Company hereunder to issue and sell the Shares and the Warrant
      to a Purchaser at the Closing is subject to the satisfaction, at or before
      the
      Closing Date of each of the following conditions thereto, provided that these
      conditions are for the Company’s sole benefit and may be waived by the Company
      at any time in its sole discretion:

     

    a. The
      applicable Purchaser shall have executed this Agreement and delivered the same
      to the Company.

     

    b. The
      applicable Purchaser shall have delivered the Purchase Price in accordance
      with
      Section 1(b) above.

     

    c. The
      representations and warranties of the applicable Purchaser shall be true and
      correct in all material respects as of the date when made and as of the Closing
      Date as though made at that time (except for representations and warranties
      that
      speak as of a specific date), and the applicable Purchaser shall have performed,
      satisfied and complied in all material respects with the covenants, agreements
      and conditions required by this Agreement to be performed, satisfied or complied
      with by the applicable Purchaser at or prior to the Closing Date. 

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    

     

    8. CONDITIONS
      TO THE BUYER’S OBLIGATION TO PURCHASE.
      The
      obligation of the Purchaser hereunder to purchase the Shares and the Warrant
      at
      the Closing is subject to the satisfaction, at or before the Closing Date of
      each of the following conditions, provided that these conditions are for such
      Purchaser’s sole benefit and may be waived by such Purchaser at any time in its
      sole discretion:

     

    a. The
      Company shall have executed this Agreement and delivered the same to the
      Purchaser.

     

    b. The
      Company shall have delivered to such Purchaser duly executed the Warrant in
      accordance with Section 1(b) above.

     

    c. The
      representations and warranties of the Company shall be true and correct in
      all
      material respects as of the date when made and as of the Closing Date as though
      made at such time (except for representations and warranties that speak as
      of a
      specific date) and the Company shall have performed, satisfied and complied
      in
      all material respects with the covenants, agreements and conditions required
      by
      this Agreement to be performed, satisfied or complied with by the Company at
      or
      prior to the Closing Date. 

     

    9. GOVERNING
      LAW; MISCELLANEOUS.
      

     

    a. Governing
      Law.
      THIS
      AGREEMENT SHALL BE ENFORCED, GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
      LAWS OF THE STATE OF NEVADA APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED
      ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICT OF
      LAWS. THE PARTIES HERETO HEREBY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE
      UNITED STATES FEDERAL COURTS LOCATED IN LOS ANGELES COUNTY, CALIFORNIA WITH
      RESPECT TO ANY DISPUTE ARISING UNDER THIS AGREEMENT, THE AGREEMENTS ENTERED
      INTO
      IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.
      BOTH
      PARTIES IRREVOCABLY WAIVE THE DEFENSE OF AN INCONVENIENT FORUM TO THE
      MAINTENANCE OF SUCH SUIT OR PROCEEDING. BOTH PARTIES FURTHER AGREE THAT SERVICE
      OF PROCESS UPON A PARTY MAILED BY FIRST CLASS MAIL SHALL BE DEEMED IN EVERY
      RESPECT EFFECTIVE SERVICE OF PROCESS UPON THE PARTY IN ANY SUCH SUIT OR
      PROCEEDING. NOTHING HEREIN SHALL AFFECT EITHER PARTY’S RIGHT TO SERVE PROCESS IN
      ANY OTHER MANNER PERMITTED BY LAW. BOTH PARTIES AGREE THAT A FINAL
      NON-APPEALABLE JUDGMENT IN ANY SUCH SUIT OR PROCEEDING SHALL BE CONCLUSIVE
      AND
      MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON SUCH JUDGMENT OR IN ANY OTHER
      LAWFUL MANNER. THE PARTY WHICH DOES NOT PREVAIL IN ANY DISPUTE ARISING UNDER
      THIS AGREEMENT SHALL BE RESPONSIBLE FOR ALL FEES AND EXPENSES, INCLUDING
      ATTORNEYS’ FEES, INCURRED BY THE PREVAILING PARTY IN CONNECTION WITH SUCH
      DISPUTE.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    

     

    b. Counterparts;
      Signatures by Facsimile.
      This
      Agreement may be executed in one or more counterparts, each of which shall
      be
      deemed an original but all of which shall constitute one and the same agreement
      and shall become effective when counterparts have been signed by each party
      and
      delivered to the other party. This Agreement, once executed by a party, may
      be
      delivered to the other party hereto by facsimile transmission of a copy of
      this
      Agreement bearing the signature of the party so delivering this
      Agreement.

     

    c. Headings.
      The
      headings of this Agreement are for convenience of reference only and shall
      not
      form part of, or affect the interpretation of, this Agreement. 

     

    d. Entire
      Agreement; Amendments.
      This
      Agreement and the instruments referenced herein contain the entire understanding
      of the parties with respect to the matters covered herein and therein and,
      except as specifically set forth herein or therein, neither the Company nor
      the
      Purchaser makes any representation, warranty, covenant or undertaking with
      respect to such matters. No provision of this Agreement may be waived or amended
      other than by an instrument in writing signed by the party to be charged with
      enforcement. 

     

    e. Notices.
      Any
      notices required or permitted to be given under the terms of this Agreement
      shall be sent by certified or registered mail (return receipt requested) or
      delivered personally or by courier (including a recognized overnight delivery
      service) or by facsimile and shall be effective five days after being placed
      in
      the mail, if mailed by regular United States mail, or upon receipt, if delivered
      personally or by courier (including a recognized overnight delivery service)
      or
      by facsimile, in each case addressed to a party. The addresses for such
      communications shall be:

     

    If
      to the
      Company:

    

    Innofone.com,
      Inc.

    1431
      Ocean Ave., Suite 1100

    Santa
      Monica, California 90401

    Attention:
      Chief Executive Officer

    Telephone:
      (310) 458-3233 

    Facsimile:
      (310) 458-2844 

     

    With
      a
      copy to:

     

    Dreier
      Stein & Kahan LLP

    1620
      26th
      Street

    Sixth
      Floor, North Tower

    Santa
      Monica, California 90404

    Attention:
      Gerard Casale, Esq.

    Telephone:
      (424) 202-6026

    Facsimile:
      (424) 202-6226

     

    If
      to a
      Purchaser: To the address set forth immediately below such Purchaser’s name on
      the signature pages hereto.

     

    Each
      party shall provide notice to the other party of any change in
      address.

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    

     

    f. Successors
      and Assigns.
      This
      Agreement shall be binding upon and inure to the benefit of the parties and
      their successors and assigns. Neither the Company nor any Purchaser shall assign
      this Agreement or any rights or obligations hereunder without the prior written
      consent of the other. Notwithstanding the foregoing, subject to
      Section 2(f), any Purchaser may assign its rights hereunder to any person
      that purchases Securities in a private transaction from a Purchaser or to any
      of
      its “affiliates,” as that term is defined under the 1934 Act, without the
      consent of the Company.

     

    g. Third
      Party Beneficiaries.
      This
      Agreement is intended for the benefit of the parties hereto and their respective
      permitted successors and assigns, and is not for the benefit of, nor may any
      provision hereof be enforced by, any other person.

     

    h. Further
      Assurances.
      Each
      party shall do and perform, or cause to be done and performed, all such further
      acts and things, and shall execute and deliver all such other agreements,
      certificates, instruments and documents, as the other party may reasonably
      request in order to carry out the intent and accomplish the purposes of this
      Agreement and the consummation of the transactions contemplated
      hereby.

     

    i. No
      Strict Construction.
      The
      language used in this Agreement will be deemed to be the language chosen by
      the
      parties to express their mutual intent, and no rules of strict construction
      will
      be applied against any party.

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF,
      the
      undersigned Purchaser and the Company have caused this Agreement to be duly
      executed as of the date first above written.

     

    

    

    INNOFONE.COM,
      INC.

    

    ________________________________

    Alex
      Lightman

    Chief
      Executive Officer 

    

    

    JAMES
      AND LISA GOODELL

    

    ______________________________________

    

    ______________________________________

    

    

    

    RESIDENCE:
      Kansas, USA

    

    ADDRESS: 1178
      17th
      Avenue

    McPherson,
      Kansas 67460

    Telephone:
      (620) 241-8321

    

    AGGREGATE
      SUBSCRIPTION AMOUNT:

    

    
      	
              Aggregate
                Purchase Price:

            	 	
              $

            	
              50,000

            	 
	
              Number
                of Shares of Common Stock:

            	 	 	
              769,230

            	 
	
              Number
                of Shares Purchasable under Warrant:

            	 	 	
              769,230

            	 

    

    

    

    

    
      
        
        

      

      
        11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]